KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to -$86.0 million.

  • Exact Sciences' Consolidated Net Income rose 9005.5% to -$86.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$208.0 million, marking a year-over-year increase of 7978.64%. This contributed to the annual value of -$208.0 million for FY2025, which is 7978.46% up from last year.
  • As of Q4 2025, Exact Sciences' Consolidated Net Income stood at -$86.0 million, which was up 9005.5% from -$19.6 million recorded in Q3 2025.
  • Over the past 5 years, Exact Sciences' Consolidated Net Income peaked at $794000.0 during Q3 2023, and registered a low of -$864.6 million during Q4 2024.
  • In the last 5 years, Exact Sciences' Consolidated Net Income had a median value of -$93.6 million in 2025 and averaged -$133.0 million.
  • As far as peak fluctuations go, Exact Sciences' Consolidated Net Income surged by 10053.37% in 2023, and later tumbled by 491561.71% in 2024.
  • Over the past 5 years, Exact Sciences' Consolidated Net Income (Quarter) stood at -$220.6 million in 2021, then soared by 42.09% to -$127.8 million in 2022, then surged by 61.05% to -$49.8 million in 2023, then crashed by 1637.3% to -$864.6 million in 2024, then surged by 90.05% to -$86.0 million in 2025.
  • Its Consolidated Net Income stands at -$86.0 million for Q4 2025, versus -$19.6 million for Q3 2025 and -$1.2 million for Q2 2025.